Pathologic response to preoperative therapy

Does it mean what we think it means?

John C. Mansour, Roderich E. Schwarz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Tumors treated with preoperative chemotherapy or radiation often demonstrate evidence of response in the resection specimen. Pathologic response is often interpreted as a surrogate for recurrence or survival outcomes. With a valid surrogate for long-term outcomes, investigators can explore treatment strategies with immediate endpoints. The financial and time costs of trials measuring recurrence and survival may be lessened by using short-term pathologic outcomes as an endpoint. This review is intended to examine the current status of pathologic response as a surrogate for tumor behavior. We address questions regarding the definitions of pathologic response, as well as the current literature regarding the meaning of pathologic response for some common tumor types. We explore some of the potential confounding effects that may explain the frequent discordance between tumor response and patient outcomes. In addition, we address some alternative strategies to gauge the response of a tumor to preoperative therapy.

Original languageEnglish (US)
Pages (from-to)1465-1479
Number of pages15
JournalAnnals of Surgical Oncology
Volume16
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Neoplasms
Therapeutics
Recurrence
Survival
Research Personnel
Radiation
Costs and Cost Analysis
Drug Therapy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Pathologic response to preoperative therapy : Does it mean what we think it means? / Mansour, John C.; Schwarz, Roderich E.

In: Annals of Surgical Oncology, Vol. 16, No. 6, 06.2009, p. 1465-1479.

Research output: Contribution to journalArticle

@article{60339cac438d47b4b9538e87b3087c20,
title = "Pathologic response to preoperative therapy: Does it mean what we think it means?",
abstract = "Tumors treated with preoperative chemotherapy or radiation often demonstrate evidence of response in the resection specimen. Pathologic response is often interpreted as a surrogate for recurrence or survival outcomes. With a valid surrogate for long-term outcomes, investigators can explore treatment strategies with immediate endpoints. The financial and time costs of trials measuring recurrence and survival may be lessened by using short-term pathologic outcomes as an endpoint. This review is intended to examine the current status of pathologic response as a surrogate for tumor behavior. We address questions regarding the definitions of pathologic response, as well as the current literature regarding the meaning of pathologic response for some common tumor types. We explore some of the potential confounding effects that may explain the frequent discordance between tumor response and patient outcomes. In addition, we address some alternative strategies to gauge the response of a tumor to preoperative therapy.",
author = "Mansour, {John C.} and Schwarz, {Roderich E.}",
year = "2009",
month = "6",
doi = "10.1245/s10434-009-0374-z",
language = "English (US)",
volume = "16",
pages = "1465--1479",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Pathologic response to preoperative therapy

T2 - Does it mean what we think it means?

AU - Mansour, John C.

AU - Schwarz, Roderich E.

PY - 2009/6

Y1 - 2009/6

N2 - Tumors treated with preoperative chemotherapy or radiation often demonstrate evidence of response in the resection specimen. Pathologic response is often interpreted as a surrogate for recurrence or survival outcomes. With a valid surrogate for long-term outcomes, investigators can explore treatment strategies with immediate endpoints. The financial and time costs of trials measuring recurrence and survival may be lessened by using short-term pathologic outcomes as an endpoint. This review is intended to examine the current status of pathologic response as a surrogate for tumor behavior. We address questions regarding the definitions of pathologic response, as well as the current literature regarding the meaning of pathologic response for some common tumor types. We explore some of the potential confounding effects that may explain the frequent discordance between tumor response and patient outcomes. In addition, we address some alternative strategies to gauge the response of a tumor to preoperative therapy.

AB - Tumors treated with preoperative chemotherapy or radiation often demonstrate evidence of response in the resection specimen. Pathologic response is often interpreted as a surrogate for recurrence or survival outcomes. With a valid surrogate for long-term outcomes, investigators can explore treatment strategies with immediate endpoints. The financial and time costs of trials measuring recurrence and survival may be lessened by using short-term pathologic outcomes as an endpoint. This review is intended to examine the current status of pathologic response as a surrogate for tumor behavior. We address questions regarding the definitions of pathologic response, as well as the current literature regarding the meaning of pathologic response for some common tumor types. We explore some of the potential confounding effects that may explain the frequent discordance between tumor response and patient outcomes. In addition, we address some alternative strategies to gauge the response of a tumor to preoperative therapy.

UR - http://www.scopus.com/inward/record.url?scp=67349083499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349083499&partnerID=8YFLogxK

U2 - 10.1245/s10434-009-0374-z

DO - 10.1245/s10434-009-0374-z

M3 - Article

VL - 16

SP - 1465

EP - 1479

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 6

ER -